Systemic dendritic cell mobilization associated with administration of FLT3 ligand to SIV- and SHIV-infected macaques

AIDS Research and Human Retroviruses

Volumn 25, Issue 12, 2009, Pages 1313-1328

  Reeves, R Keith ^a,b   Wei, Qing ^a   Stallworth, Jackie ^a   Fultz, Patricia N ^a  

^a University of Alabama at Birmingham   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD69 ANTIGEN; FLT3 LIGAND; HLA DR ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; FEMALE; LYMPH NODE; LYMPHOID TISSUE; MALE; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS INFECTION; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; INTERFERON-ALPHA; INTERLEUKIN-12; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MACACA NEMESTRINA; MALE; MEMBRANE PROTEINS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 73149121954     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0053     Document Type: Article

References (99)

1. Kohrgruber N, Halanek N, Groger M, et al.: Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines. J Immunol 1999;163:3250-3259.
2. O'Doherty U, Peng M, Gezelter S, et al.: Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994;82:487-493.
3. Hoeffel G, Ripoche AC, Matheoud D, et al.: Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 2007;27:481-492.
4. Iwasaki A and Medzhitov R: Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004;5:987-995.
5. Reis e Sousa C: Toll-like receptors and dendritic cells: For whom the bug tolls. Semin Immunol 2004;16:27-34.
6. Siegal FP, Kadowaki N, Shodell M, et al.: The nature of the principal type 1 interferon-producing cells in human blood. Science 1999;284:1835-1837.
7. Fonteneau JF, Larsson M, Beignon AS, et al.: Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J Virol 2004;78:5223-5232.
8. Lou Y, Liu C, Kim GJ, Liu YJ, Hwu P, and Wang G: Plasmacytoid dendritic cells synergize with myeloid dendritic cells in the induction of antigen-specific antitumor immune responses. J Immunol 2007;178:1534-1541.
9. Gerosa F, Gobbi A, Zorzi P, et al.: The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol 2005;174:727-734.
10. MacDonald KPA, Rowe V, Clouston AD, et al.: Cytokine expanded myeloid precursors function as regulatory antigen- presenting cells and promote tolerance through IL-10- producing regulatory T cells. J Immunol 2005;174:1841-1850.
11. Kawamura K, Kadowaki N, Kitawaki T, and Uchiyama T: Virus-stimulated plasmacytoid dendritic cells induce CD4 + cytotoxic regulatory T cells. Blood 2006;107:1031-1038.
12. Blom B, Ho S, Antonenko S, and Liu YJ: Generation of interferon-a- producing predendritic cell (pre-DC)2 from human CD34 + hematopoietic stem cells. J Exp Med 2000; 192:1785-1795.
13. Szabolcs P, Park KD, Reese M, Marti L, Broadwater G, and Kurtzberg J: Absolute values of dendritic cell subsets in bone marrow, cord blood, and peripheral blood enumerated by a novel method. Stem Cells 2003;21:296-303.
14. Li W and Liu YJ: Development of dendritic-cell lineages. Immunity 2007;26:741-750.
15. Pinchuk LM, Grouard-Vogel G, Magaletti DM, Doty RT, Andrews RG, and Clark EA: Isolation and characterization of macaque dendritic cells from CD34 + bone marrow progenitors. Cell Immunol 1999;196:34-40.
16. Hartmann E, Graefe H, Hopert A, et al.: Analysis of plasmacytoid and myeloid dendritic cells in nasal epithelium. Clin Vaccine Immunol 2006;13:1278-1286.
17. Pashenkov M, Teleshova N, Kouwenhoven M, et al.: Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections. J Neuroimmunol 2002;122:106-116. (Pubitemid 34075496)
18. Zhao X, Deak E, Soderberg K, et al.: Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med 2003;197:153-162.
19. Middel P, Raddatz D, Gunawan B, Haller F, and Radzun HJ: Increased number of mature dendritic cells in Crohn's disease: Evidence for a chemokine mediated retention mechanism. Gut 2006;55:220-227.
20. Vandenabeele S, Hochrein H, Mavaddat N, Winkel K, and Shortman K: Human thymus contains 2 distinct dendritic cell populations. Blood 2001;97:1733-1741.
21. Summers KL, Hock BD, McKenzie JL, and Hart DNJ: Phenotypic characterization of five dendritic cell subsets in human tonsils. Am J Pathol 2001;159:285-295.
22. Masten BJ, Olson GK, Tarleton CA, et al.: Characterization of myeloid and plasmacytoid dendritic cells in human lung. J Immunol 2006;177:7784-7793.
23. Tanis W, Mancham S, Binda R, et al.: Human hepatic lymph nodes contain normal numbers of mature myeloid dendritic cells but few plasmacytoid dendritic cells. Clin Immunol 2004;110:81-88.
24. Woltman AM, de Fijter JW, Zuidwijk K, et al.: Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions. Kidney Int 2007;71:1001-1008.
25. Donaghy H, Pozniak A, Gazzard B, et al.: Loss of blood CD11c+ myeloid and CD11c- plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 2001;98:2574-2576.
26. Goutagny N, Vieux C, Decullier E, et al.: Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C infection. J Infect Dis 2004;189:1646-1655.
27. Duan XZ, Wang M, Li HW, Zhuang H, Xu D, and Wang FS: Decreased frequency and function of circulating plasmacytoid dendritic cells (pDC) in hepatitis B virus infected humans. J Clin Immunol 2004;24:637-646.
28. Feldman S, Stein D, Amrute S, et al.: Decreased interferon-a production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. Clin Immunol 2001;101:201-210.
29. Hishizawa M, Imada K, Kitawaki T, Ueda M, Kadowaki N, and Uchiyama T: Depletion and impaired interferon-aproducing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type 1-infected individuals. Br J Haematol 2004;125:568-575.
30. Zhang Z, Xu D, Li Y, et al.: Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome. Clin Immunol 2005;116:225-235.
31. Barron MA, Blyveis N, Palmer BE, MaWhinney S, andWilson CC: Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals. J Infect Dis 2003;187:26-37.
32. Brown K., Trichel A, and Barratt-Boyes SM: Parallel loss of myeloid and plasmacytoid dendritic cells from blood and lymphoid tissue in simian AIDS. J Immunol 2007;178:6958-6967.
33. Reeves RK and Fultz PN: Disparate effects of acute and chronic infection with SIVmac239 or SHIV-89.6P on macaque plasmacytoid dendritic cells. Virology 2007;365:356-368.
34. Brown KN, Wijewardana V, Liu X, and Barratt-Boyes SM: Rapid influx and death of plasmacytoid dendritic cells in lymph nodes mediate depletion in acute simian immunodeficiency virus infection. PLoS Pathog 2009;5:e1000413. doi:10.1371.
35. Reeves RK and Fultz PN: Characterization of plasmacytoid dendritic cells in bone marrow of pig-tailed macaques. Clin Vaccine Immunol 2008;15:35-41.
36. Karsunky H, Merad M, Cozzio A, Weissman IL, and Manz MG: Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J Exp Med 2003;198:305-313.
37. D'Amico A and Wu L: The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hematopoietic precursors expressing Flt3. J Exp Med 2003;198:293-303.
38. Dettke M, Jurko S, Ruger BM, et al.: Increased serum flt3- ligand in healthy donors undergoing granulocyte colonystimulating factor-induced peripheral stem cell mobilization. J Hematother Stem Cell Res 2001;10:317-320.
39. Gill MA, Blanco P, Arce E, Pascual V, Banchereau J, and Palucka AK: Blood dendritic cells and DC-poietins in systemic lupus erythematosus. Hum Immunol 2002;63:1172-1180.
40. Lyman SD, Seaberg M, Hanna R, et al.: Plasma serum levels of flt3 ligand are low in normal individuals and highly elevated in patients with Fanconi anemia and acquired aplastic anemia. Blood 1995;86:4091-4096.
41. Wodnar-Filipowicz A, Lyman SD, Gratwohl A, Tichelli A, Speck B, and Nissen C: Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia. Blood 1996;88: 4493-4499. (Pubitemid 26419132)
42. Maraskovsky E, Brasel K, Teepe M, et al.: Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified. J Exp Med 1996;184:1953-1962.
43. Shurin MR, Pandharipande PP, Zorina TD, et al.: Flt3 ligand induces the generation of functionally active dendritic cells in mice. Cell Immunol 1997;179:174-184.
44. Chklovskaia E, Nowbakht P, Nissen C, Gratwohl A, Bargetzi M, and Wodnar-Filipowicz A: Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: Effects of endogenous flt3 ligand. Blood 2004;103:3860-3868.
45. Pulendran B, Banchereau J, Burkeholder S, et al.: Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J Immunol 2000;165: 566-572.
46. Maraskovsky E, Daro E, Roux E, et al.: In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 2000;96: 878-884.
47. Coates PTH, Barratt-Boyes SM, Zhang L, et al.: Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand. Blood 2003;102: 2513-2521.
48. Teleshova N, Jones J, Kenney J, et al.: Short-term Flt3L treatment effectively mobilizes functional macaque dendritic cells. J Leukoc Biol 2004;75:1102-1110.
49. Koopman G, Niphuis H, Haaksma AGM, et al.: Increase in plasmacytoid and myeloid dendritic cells by progenipoietin- 1, a chimeric Flt-3 and G-CSF receptor agonist, in SIV-infected rhesus macaques. Hum Immunol 2004;65:303-316.
50. Koopman G, Mortier D, Niphuis H, et al.: Systemic mobilization of antigen presenting cells, with a chimeric Flt-3 and G-CSF receptor agonist, during immunization of Macaca mulatta with HIV-1 antigens is insufficient to modulate immune responses or vaccine efficacy. Vaccine 2005;23: 4195-4202.
51. Kwissa M, Amara RR, Robinson HL, et al.: Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus. J Exp Med 2007;204:2733-2746.
52. Fultz PN, Stallworth JW, Porter D, Novak M, Anderson MJ, and Morrow CD: Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease. Virology 2003;315: 425-437.
53. Wei Q, Stallworth JW, Vance PJ, Hoxie JA, and Fultz PN: Simian immunodeficiency virus (SIV) immunoglobulin G immune complexes in SIV-infected macaques block detection of CD16 but not cytolytic activity of natural killer cells. Clin Vaccine Immunol 2006;13:768-778.
54. Lifson JD, Rossio JL, Piatak M Jr, et al.: Role of CD8 + lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment. J Virol 2001;75:10187-10199.
55. Scaradavou A: HIV-related thrombocytopenia. Blood Rev 2002;16:73-76.
56. Fultz PN, Vance PJ, Endres MJ, et al.: In vivo attenuation of simian immunodeficiency virus by disruption of a tyrosinedependent sorting signal in the envelope glycoprotein cytoplasmic tail. J Virol 2001;75:278-291.
57. Wachtman LM, Tarwater PM, Queen SE, Adams RJ, and Mankowski JL: Platelet decline: An early predictive hematologic marker of simian immunodeficiency virus central nervous system disease. J Neurovirol 2006;12:25-33.
58. Romagnani C, Chiesa MD, Kohler S, et al.: Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4 + T helper cells and CD4 + CD25hi T regulatory cells. Eur J Immunol 2005;35:2452-2458.
59. Marshall JD, Heeke DS, Abbate C, Yee P, and Van Nest G: Induction of interferon-g from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid dendritic cell-produced interferon-a and tumour necrosis factor-a. Immunology 2006;117:38-46.
60. Tomescu C, Chehimi J, Maino VC, and Montaner LJ: NK cell lysis of HIV-1-infected autologous CD4 primary T cells: Requirement for IFN-mediated NK activation by plasmacytoid dendritic cells. J Immunol 2007;179:2097-2104.
61. Chehimi J, Starr SE, Frank I, et al.: Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med 1994;179:1361-1366.
62. McGinn TM, Wei Q, Stallworth JW, and Fultz PN: Immune responses to HTLV-1(ACH) during acute infection of pigtailed macaques. AIDS Res Hum Retroviruses 2004;20:443-456.
63. Mahalingam M, Peakman M, Davies ET, Pozniak A, McManus TJ, and Vergani D: T cell activation and disease severity in HIV infection. Clin Exp Immunol 1993;93:337-343.
64. Giavedoni LD, Velasquillo MC, Parodi LM, Hubbard GB, and Hodara VL: Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J Virol 2000;74:1648-1657.
65. Estes JD, Li Q, Reynolds MR, et al.: Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J Infect Dis 2006;193:703-712.
66. Tsunemi S, Iwasaki T, Imado T, et al.: Relationship of CD4 + CD25 + regulatory T cells to immune status in HIVinfected patients. AIDS 2005;19:879-886.
67. Bertho JM, Demarquay C, Frick J, et al.: Level of Flt3-ligand in plasma: A possible new bio-indicator for radiationinduced aplasia. Int J Radiat Biol 2001;77:703-712.
68. Papayannopoulou T, Nakamoto B, Andrews RG, Lyman SD, and Lee MY: In vivo effects of Flt3 Flk2 ligand on mobilization of hematopoietic progenitors in primates and potent synergistic enhancement with granulocyte colony-stimulating factor. Blood 1997;90:620-629.
69. Sigurjonsson OE, Gudmundsson KO, Haraldsdottir V, Rafnar T, and Gudmundsson S: Flt3 Flk-2-ligand in synergy with thrombopoietin delays megakaryocyte development and increases the numbers of megakaryocyte progenitor cells in serum-free cultures initiated with CD34 + cells. J Hematother Stem Cell Res 2002;11:389-400.
70. Case J, Hicks C, Trickett A, Kwan YL, and Manoharan A: The expansion of megakaryocyte progenitors from CD34 + - enriched mobilized peripheral blood stem cells is inhibited by Flt3-L. J Interferon Cytokine Res 2006;26:76-82.
71. Hartong SC, Neelis KJ, and Wagemaker G: Co-administration of Flt-3 ligand counteracts the actions of thrombopoietin in myelosuppressed rhesus monkeys. Br J Haematol 2003; 121:359-367.
72. Chen W, Antonenko S, Sederstrom JM, et al.: Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors. Blood 2004;103:2547-2553.
73. Waskow C, Liu K, Darasse-Jeze G, et al.: The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol 2008;9:676-683.
74. Merad M and Manz MG: Dendritic cell homeostasis. Blood 2009;113:3418-3427.
75. Marroquin CE, Westwood JA, Lapointe R, et al.: Mobilization of dendritic cell precursors in patients with cancer by Flt3 ligand allows the generation of higher yields of cultured dendritic cells. J Immunother 2002;25:278-288.
76. Masten BJ, Olson GK, Kusewitt DF, and Lipscomb MF: Flt3 ligand preferentially increases the number of functionally active myeloid dendritic cells in the lungs of mice. J Immunol 2004;172:4077-4083.
77. Shackleton M, Davis ID, Hopkins W, et al.: The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand. Cancer Immun 2004;4:9.
78. Vollstedt S, O'Keeffe M, Odermatt B, et al.: Treatment of neonatal mice with Flt3 ligand leads to changes in dendritic cell subpopulations associated with enhanced IL-12 and IFN-a production. Eur J Immunol 2004;34:1849-1860.
79. Lehmann C, Harper JM, Taubert D, et al.: Increased interferon alpha expression in circulating plasmacytoid dendritic cells in HIV-1-infected patients. J Acquir Immune Defic Syndr 2008;48:522-530.
80. Tilton JC, Manion MM, Luskin MR, et al.: Human Immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. J Virol 2008;82:3997-4006.
81. Moseman EA, Liang X, Dawson AJ, et al.: Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4 + CD25 + regulatory T cells. J Immunol 2004;173:4433-4442.
82. Dhodapkar MV and Steinman RM: Antigen-bearing immature dendritic cells induce peptide-specific CD8 + regulatory T cells in vivo in humans. Blood 2002;100:174-177.
83. Chen X, Baumel M, Mannel DN, Howard OM, and Oppenheim JJ: Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4 + CD25 + T regulatory cells. J Immunol 2007;179:154-161.
84. Manches O, Munn D, Fallahi A, et al.: HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3- dioxygenase-dependent mechanism. J Clin Invest 2008;118: 3431-3439.
85. Malleret B, Maneglier B, Karlsson I, et al.: Primary infection with simian immunodeficiency virus: Plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression. Blood 2008;112:4598-4608.
86. Karlsson I, Malleret B, Brochard P, et al.: FoxP3 + CD25 + CD8 + T-cell induction during primary simian immunodeficiency virus infection in cynomolgus macaques correlates with low CD4 + T-cell activation and high viral load. J Virol 2007;81:13444-13455.
87. Sedaghat AR, German J, Teslovich TM, et al.: Chronic CD4 + T-cell activation and depletion in human immunodeficiency virus type 1 infection: Type I interferon-mediated disruption of T-cell dynamics. J Virol 2008;82:1870-1883.
88. Nilsson J, Boasso A, Velilla PA, et al.: HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV=AIDS. Blood 2006;108: 3808-3817.
89. Piccirillo CA and Shevach EM: Naturally occurring CD4 + CD25 + immunoregulatory T cells: Central players in the arena of peripheral tolerance. Semin Immunol 2004;16:81-88.
90. Shaw SG, Maung AA, Steptoe RJ, Thomson AW, and Vujanovic NL: Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: Implications for anti-cancer and anti-viral therapy. J Immunol 1998;161:2817-2824.
91. Biron CA, Nguyen KB, Pien GC, Cousens LP, and Salazar- Mather TP: Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu Rev Immunol 1999;17:189-220.
92. Hu PF, Hultin LE, Hultin P, et al.: Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16 + CD56 + cells and expansion of a population of CD16dimCD56- cells with low lytic activity. J Acquir Immune Defic Syndr 1995;10:331-340.
93. Azzoni L, Rutstein RM, Chehimi J, Farabaugh MA, Nowmos A, and Montaner LJ: Dendritic and natural killer cell subsets associated with stable or declining CD4 + cell counts in treated HIV-1-infected children. J Infect Dis 2005;191:1451-1459.
94. Mansour I, Doinel C, and Rouger P: CD16 + NK cells decrease in all stages of HIV infection through a selective depletion of the CD16 + CD8 + CD3- subset. AIDS Res Hum Retroviruses 1990;6:1451-1457.
95. Bucur SZ, Lackey DA, Adams JW, et al.: Hematologic and virologic effects of lineage-specific and non-lineage-specific recombinant human and rhesus cytokines in a cohort of SIVmac239-infected macaques. AIDS Res Hum Retroviruses 1998;14:651-660.
96. Morelli AE, Coates PT, Shufesky WJ, et al.: Growth factorinduced mobilization of dendritic cells in kidney and liver of rhesus macaques: Implications for transplantation. Transplantation 2007;83:656-662.
97. Lee CI, Cowan MJ, Kohn DB, and Tarantal AF: Simian immunodeficiency virus infection of hematopoietic stem cells and bone marrow stromal cells. J Acquir Immune Defic Syndr 2004;36:553-561.
98. Thiebot H, Louache F, Vaslin B, et al.: Early and persistent bone marrow hematopoiesis defect in simian=human immunodeficiency virus-infected macaques despite efficient reduction of viremia by highly active antiretroviral therapy during primary infection. J Virol 2001;75:11594-11602.
99. Folks TM, Kessler SW, Orenstein JM, Justement JS, Jaffe ES, and Fauci AS: Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow. Science 1988;242:919-922.